Poland approves Tilray Medical products for distribution and wholesale


Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) the medical division continues to expand its presence across Europe and has added Poland to its distribution list.

On Wednesday, the cannabis producer with multinational operations announced that its products are now approved by the Polish Ministry of Health for the distribution and wholesale of pharmaceutical products.

In Poland, the company has established multiple partnerships with pharmaceutical companies to distribute both Tilray-branded and non-branded products. Polish patients can access cannabis through medical prescriptions.

Read more: Tilray Medical expands UK portfolio

Read more: Luxembourg health authorities visit Tilray Medical facilities in Portugal

“I am extremely proud of our team in Europe for once again extending our approved clearance for Tilray Medical products across Europe. Tilray will continue to advocate for reasonable patient access to reliable, high-quality medical cannabis in Europe and countries around the world,” said CSO Denise Faltischek.

Tilray Medical is an international supplier of EU GMP certified medical cannabis products in 21 countries and offers brands such as Tilray, Aphria, Broken Coast and Symbios. It is one of the first companies in Canada to have built a production plant in Europe and is now one of the largest suppliers of medical pot.

The company’s shares fell 2.41 Wednesday to $5.26 on the Toronto Stock Exchange.

Follow Mugglehead on Twitter

Like Mugglehead on Facebook


Comments are closed.